Showing results (341-350 of 531) with videos related to

Sort By:
Pageof 54
Pharmacoeconomics|August 4, 2026
External Validation of SELECT Trial-Derived Cardiovascular Risk Equations in a UK Population with Overweight or Obesity and Established Cardiovascular Disease Without DiabetesFelice Gragnano, Martin Bøg, Anders Bo Bojesen, et al.
Diabetes & Vascular Disease Research|April 25, 2019
Baseline fasting plasma insulin levels predict risk for major adverse cardiovascular events among patients with diabetes and high-risk vascular disease: Insights from the ACCELERATE trialAnirudh Kumar, Divyang R Patel, Kathy E Wolski, et al.
The American Journal of Cardiology|September 16, 2020
Implementation of a Comprehensive ST-Elevation Myocardial Infarction Protocol Improves Mortality Among Patients With ST-Elevation Myocardial Infarction and Cardiogenic ShockAnirudh Kumar, Chetan P Huded, Leon Zhou, et al.
Lancet (London, England)|January 15, 2000
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for StentingE J Topol, D B Mark, A M Lincoff, et al.
Chest|February 9, 2012
Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesPer Olav Vandvik, A Michael Lincoff, Joel M Gore, et al.
American Heart Journal|July 12, 2011
Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialJeffrey S Berger, Deepak L Bhatt, P Gabriel Steg, et al.
The American Journal of Cardiology|March 7, 2001
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin TherapyJ G Peterson, E J Topol, M T Roe, et al.
Circulation|December 6, 2001
Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trialM A Lauer, P L Houghtaling, J G Peterson, et al.
American Heart Journal|November 4, 2004
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationaleGregg W Stone, Michel Bertrand, Antonio Colombo, et al.
The American Journal of Cardiology|March 4, 2008
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whitesGian M Novaro, Craig R Asher, Deepak L Bhatt, et al.
Pageof 54